Funding Opportunity Announcement: Advancing Novel Medical Isotopes for Clinical Trials
The DOE Office of Science is excited to announce a new Funding Opportunity for up to $2 million to support translational research and development (R&D) of novel, medically relevant isotopes to accelerate evaluation for usage in pre-clinical and clinical trials.
“This funding will advance research to evaluate new isotopes for use in pre-clinical and clinical trials, with potentially enormous benefits to the field of modern medicine,” said Jehanne Gillo, Director of the DOE Isotope Program.
While the DOE Isotope Program introduces novel isotopes to the medical community for evaluation, the support of pre-clinical and clinical trials is not part of the mission of the DOE Isotope Program, or consequently this FOA.
Applications are open to all accredited U.S. colleges and universities, national laboratories, nonprofits, and private sector companies. Awards are envisioned for both single investigators and small multi-institutional collaborations. Total planned funding is $2 million, with all funding available in the fiscal year 2022, contingent on congressional appropriations.
Final applications for this funding opportunity are due on July 23, 2021, by 11:59 pm ET. For more information and to read the full text of the Funding Opportunity Announcement, follow the link below.